China Meheco Group Co (600056.SS) Stock Price

China Meheco Group Co Price

SSE·CLOSED
8.86
​
Market closed

Revenue has compounded at 14.5% per year over the past 19 years to 35.36 B CNY. Earnings per share have grown at 5.4% per year over the last 19 years. China Meheco Group Co's net margin stands at 1.3%, broadly stable from 1.8% several years earlier. China Meheco Group Co currently offers a dividend yield of about 0.22%. The payout ratio is around 6% of earnings.

China Meheco Group Co stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

China Meheco Group Co business model & stock analysis

China Meheco Group Co., Ltd. generates revenue through its Industrial Pharmaceutical segment, which manufactures and distributes chemical preparations, chemical bulk drugs, biological products, Chinese patent medicine, and herbal decoction pieces. The Commercial Pharmaceutical segment focuses on wholesale and distribution of pharmaceuticals and medical devices. The Trading segment handles international exporting and medical resourcing introduction. The company serves healthcare providers, hospitals, and pharmacies through its wholesale operations, targeting the pharmaceutical and medical device markets in China and internationally. The Industrial Pharmaceutical segment produces chemical preparations, chemical bulk drugs, biological products, Chinese patent medicine, and herbal decoction pieces for distribution. The Commercial Pharmaceutical segment supplies pharmaceuticals and medical devices to healthcare institutions and retailers. The Trading segment facilitates international exports of pharmaceutical products and introduces medical resources globally, catering to global healthcare markets. China Meheco's revenue streams are derived from the sale of pharmaceutical products across its three segments. The Industrial segment manufactures and sells chemical and traditional Chinese medicine products, while the Commercial segment distributes these products through wholesale channels. The Trading segment earns from exporting pharmaceuticals and managing international medical resource procurement for global clients.

Frequently asked questions about China Meheco Group Co

5 analysts currently rate the China Meheco Group Co stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect China Meheco Group Co to generate revenue of 29.55 B CNY and earnings per share of 0.82 CNY.

Converted at the current exchange rate, the China Meheco Group Co share trades at 1.18 EUR (8.86 CNY).

The China Meheco Group Co share (600056.SS) is listed on 1 stock exchanges, including: Shanghai (600056.SS).

The expected revenue of China Meheco Group Co is 29.55 B CNY. This figure is based on current financial data and reflects the company's business performance.

The expected profit of China Meheco Group Co is 1.22 B CNY. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of China Meheco Group Co is currently 10.83. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the China Meheco Group Co stock.

The price-to-sales ratio (P/S) of China Meheco Group Co is currently 0.45. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the China Meheco Group Co stock.

The Eulerpool Quality Score for China Meheco Group Co is 4/10.

The ISIN of China Meheco Group Co is CNE000000Q29. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of China Meheco Group Co is 600056.SS. The ticker symbol is used to trade China Meheco Group Co shares on the stock exchange.

Fair ValueTerminal
7.89 CNY
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Providers & Services
Number of shares
Employees
Revenue per Employee
4.25 M CNY
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website meheco.com
Country
Currency
CNY
Initial public offering
May 15, 1997
ISIN
CNE000000Q29
Cusip
Y16635107
Market capitalization
13.25 B CNYLarge Cap
52-Week Range
PEG
5.79
P/E ratio
P/Ee 2026
10.83
P/Ee 2027
8.48
P/Ee 2028
10.34
P/Ee 2029
9.40
P/Ee 2030
8.55
P/S
P/Se
0.45
EV/EBIT
8.37
P/B Ratio
1.12
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
3.78 %
Dividend
Dividend yield
0.22 %
Est. Dividend Yield
0.44 %
Payout Ratio
6.21 %
Dividend growth Ø5Y
3.34 %
Dividend payments per year
2
Dividend paid since
16 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
10.00 %
Last updated Oct 23, 2026, 5:32 PM

China Meheco Group Co Peer Group

China Meheco Group Co Ticker

SHH · 600056.SS

China Meheco Group Co FIGI

600056:CH · BBG000BH73V1600056:CG · BBG000BH74L0600056:C1 · BBG00709HCG2